Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Surjit Bhai | Computational Chemistry | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Surjit Bhai
Assam down town University

Surjit Bhai
Affiliation Assam down town University
Country India
Scholar ID 74fJslYAAAAJ
Documents 18
Citations 126
h-index 6
Subject Area Computational Chemistry
Event Indian Scientist Awards

Surjit Bhai is an academic researcher affiliated with Assam down town University, India. His research activities are primarily associated with Computational Chemistry, an interdisciplinary field integrating chemistry, mathematics, physics, and computer science to investigate molecular structures, chemical processes, and predictive scientific models. His documented scholarly record reflects sustained academic engagement through publications, citations, and research dissemination activities that contribute to the advancement of computational and theoretical chemical sciences.[1]

Abstract

The Innovative Research Award recognizes scholarly contributions that demonstrate originality, scientific relevance, and sustained academic productivity. Surjit Bhai’s research profile highlights active participation in Computational Chemistry, supported by a measurable publication record and citation impact. His academic contributions align with contemporary research priorities involving computational modeling, molecular simulations, and theoretical investigations that support scientific discovery and technological advancement.[1][2]

Keywords

Computational Chemistry; Molecular Modeling; Chemical Informatics; Quantum Chemistry; Scientific Computing; Innovative Research; Theoretical Chemistry; Research Excellence; Chemical Simulations; Academic Scholarship.

Introduction

Computational Chemistry has emerged as a critical scientific discipline that enables researchers to investigate molecular behavior and chemical interactions through computational methods. The field contributes significantly to materials science, pharmaceutical research, environmental studies, and molecular engineering. Recognition programs such as the Innovative Research Award acknowledge researchers whose scholarly efforts contribute to expanding scientific understanding and innovation within these domains.[2]

Research Profile

According to available scholarly metrics, Surjit Bhai has produced eighteen documented research publications and accumulated one hundred twenty-six citations, with an h-index of six. These indicators reflect academic visibility and engagement within the scientific community. His research interests focus on computational approaches to chemical analysis, molecular systems, and theoretical investigations that support scientific advancement.[1]

  • Research specialization in Computational Chemistry.
  • Experience in molecular modeling and computational analysis.
  • Contribution to peer-reviewed scientific literature.
  • Participation in interdisciplinary scientific research initiatives.

Research Contributions

The research contributions associated with Surjit Bhai emphasize the application of computational techniques to investigate chemical structures, reaction mechanisms, and molecular properties. Such work supports efficient scientific experimentation by complementing laboratory-based investigations with predictive computational frameworks. Computational Chemistry continues to play an important role in accelerating scientific discovery and reducing experimental complexity across multiple disciplines.[2][3]

  • Computational investigation of molecular systems.
  • Development and application of theoretical chemical models.
  • Support for data-driven scientific analysis.
  • Contribution to interdisciplinary computational research.

Publications

The researcher’s publication portfolio reflects continued scholarly engagement and participation in academic communication. Published works contribute to the dissemination of scientific knowledge and provide opportunities for peer review, validation, and future research development.[1]

  1. Peer-reviewed journal articles in Computational Chemistry.
  2. Research papers involving molecular simulations and theoretical studies.
  3. Conference publications and scientific communications.
  4. Collaborative interdisciplinary research outputs.

Research Impact

Citation-based indicators provide one perspective on scholarly influence and visibility. The research profile associated with Surjit Bhai demonstrates measurable academic impact through citation activity and publication performance. These indicators suggest that his work contributes to ongoing scientific discussions and supports further investigations within Computational Chemistry and related disciplines.[1]

Award Suitability

The Innovative Research Award recognizes originality, scientific rigor, and meaningful scholarly contributions. Based on available academic metrics and documented research activities, Surjit Bhai demonstrates characteristics commonly associated with innovative scientific inquiry, including publication productivity, citation impact, and engagement with computational methodologies that address contemporary scientific challenges. These attributes support consideration for recognition within research excellence programs.[1][4]

Conclusion

Surjit Bhai’s academic profile reflects continued contributions to Computational Chemistry through scholarly publication, citation impact, and research engagement. His work contributes to the broader advancement of computational scientific methodologies and supports knowledge development within chemistry-related disciplines. The Innovative Research Award provides an appropriate framework for recognizing such contributions and encouraging future academic achievements.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Surjit Bhai, Scholar ID 74fJslYAAAAJ. https://scholar.google.com/citations?user=74fJslYAAAAJ&hl=en
  2. Recyclable Functionalized Material for Sensitive Detection and Exceptional Sorption of Hexavalent Chromium and Permanganate Ions with Biosensing ApplicationsClick to copy article link. https://pubs.acs.org/doi/abs/10.1021/acsabm.1c00609
  3. Estimation of bisulfate in edible plant foods, dog urine, and drugs: picomolar level detection and bio-imaging in living organisms†
    https://pubs.rsc.org/en/content/articlelanding/2017/vz/c9an01078e/unauth
  4. Probing the Interaction of Nucleobases and Fluorophore-Tagged Nucleobases with Graphene Surface: Adsorption and Fluorescence Studies.
    https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/slct.201904442

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Dr. Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dayananda Sagar University, India

Dr. Gnana Ruba Priya Muthaiya is an accomplished pharmaceutical chemist and academician with advanced expertise in medicinal chemistry and drug design. Holding doctoral and postgraduate qualifications in pharmaceutical sciences, she has extensive experience in teaching, research, and mentoring across pharmacy disciplines. Her research focuses on computer-aided drug discovery, green synthesis, and anticancer therapeutics. With numerous peer-reviewed publications, patents, and scientific contributions, she has earned recognition for research excellence. Her work reflects a strong commitment to innovative drug development and impactful advancements in healthcare science.

Citation Metrics (Scopus)

70
50
30
10
0

Citations
60

Documents
1

h-index
1

Citations

Documents

h-index

Featured Publications


Artificial intelligence in screening: Models versus experiments


– Drug Discovery Today (Cited by 93 · Year: 2022)

Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Published-on by Indian Scientist

Mr. Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Vidya University | India

Rahul Kumar is an Assistant Professor in Pharmacy with expertise in Computer-Aided Drug Design and Pharmaceutical Chemistry. He holds professional training in pharmaceutical sciences and contributes to teaching and research in drug discovery, molecular modeling, and computational chemistry. His research focuses on CADD, medicinal chemistry, biosensors, and AI-driven approaches in healthcare. He has authored peer-reviewed publications, book chapters, and patents, and has received national-level research and innovation awards, reflecting a strong commitment to academic excellence and translational research.

Citation Metrics (Scopus)

20
15
10
5
0

Citations
11

h-index
1

Documents
1

Citations

h-index

Documents

Featured Publications

Citation counts are indicative and may vary across databases; all links redirect to open Google Scholar search results.

Ritu Dahiya | Pharmacology | Research Excellence Award

Published-on by Indian Scientist

Ritu Dahiya | Pharmacology | Research Excellence Award

Linagyas Vidyapeeth  University | India

Dr. Ritu is an accomplished academician and researcher in pharmacology, serving as an Associate Professor with extensive teaching, research, and academic leadership experience. She holds foundational and advanced degrees in pharmacy and is completing her doctoral work in pharmacology. Her professional journey spans university teaching, funded research fellowships, interdisciplinary program development, and scientific mentoring. She has developed expertise in diabetes and its complications, ocular pharmacology, infectious-disease therapeutics, biomarker discovery, and nano-based drug delivery. Her research contributions include high-quality publications in indexed journals, multiple book chapters, edited academic books, and several national and international patents that demonstrate her innovative approach to translational research. She has guided postgraduate dissertations and contributed significantly to curriculum development, scientific event organization, and student training. She has also served as a resource person, evaluator, and invited speaker at scientific conferences and academic forums where her contributions have been recognized through awards and professional acknowledgments. Her work continually focuses on bridging laboratory discovery with therapeutic advancement, especially through natural products, bioflavonoids, molecular mechanisms, and innovative models for disease evaluation. Overall, she is dedicated to advancing pharmacological sciences, fostering research-driven education, and contributing impactful scientific knowledge to improve human health.

Citation Metrics (Google Scholar)

50
38
10
5
0

Citations
48

i10index
2

h-index
4

Citations

i10-index

h-index


View Google Scholar Profile

Featured Publications

Satyamvada Maurya | Computational Biology | Best Researcher Award

Published-on by Indian Scientist

Mrs. Satyamvada Maurya | Computational Biology | Best Researcher Award

ICAR-National Bureau of Fish Genetic Resources | India

Dr. Satyamvada Maurya is a bioinformatics researcher with extensive experience in genomics, computational biology, and drug discovery. She holds a Ph.D. in Bioinformatics, focusing on the design and development of novel anti-tuberculosis agents through computational approaches. Her academic foundation includes a Master’s in Bioinformatics and a Bachelor’s in Biotechnology, which laid the groundwork for her multidisciplinary research. She has worked as a Project Assistant and Young Professional in premier Indian research institutes, contributing to projects in genome analysis, database development, SNP characterization, and functional genomics of aquatic organisms, particularly Clarias magur. Her research interests span next-generation sequencing, genome analysis, protein structure-function prediction, drug design, homology modeling, phylogenetic analysis, and database creation for biological resources. She has authored multiple research articles, book chapters, training manuals, and popular science articles, accumulating 27 citations with an h-index of 3 and i10-index of 1, reflecting the impact of her work. She has received awards including the TEQIP fellowship and best presentation accolades at national and international conferences. Dr. Maurya is committed to advancing bioinformatics applications in both healthcare and aquaculture, bridging computational tools with experimental biology to address complex biological challenges. Her work continues to contribute to the development of innovative solutions in genomics and drug discovery.

Profile: Google Scholar

Featured Publications

Verma, S., Maurya, R., & Maurya, S. (2016). Prediction of gene action and combining ability for yield and quality traits in F1 and F2 generations of wheat (Triticum aestivum L.). Tropical Plant Research, 3(2), 449–459.

Maurya, S., Jain, A., Singh, V., Haque, S., & Mishra, B. N. (2023). Evaluation of Saraca asoca for its anti-tubercular potential via molecular docking and molecular dynamics simulation studies. ChemistrySelect, 8(12), e202204899.

Maurya, S., Alhazmi, A., Vidyarthi, A. S., Jain, A., Singh, V., Khan, F., Haque, S., & Mishra, B. N. (2022). In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv. Minerva Biotechnology & Biomolecular Research, 34(2), 71–79.

Maurya, S., Kumar, M. S., Kumar, R., & Kushwaha, B. (2024). Role of machine learning and artificial intelligence in transforming aquaculture and fisheries sector. Indian Farming, 74(8), 24–27.

Maurya, S., Jain, A., Rehman, M. T., Hakamy, A., Bantun, F., AlAjmi, M. F., Singh, V., … Mishra, B. N. (2023). In silico identification of novel derivatives of rifampicin targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin derivatives target VapC2 of Mtb H37Rv. Molecules, 28(4), 1652.

Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Published-on by Indian Scientist

Mr. Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Central University of Punjab | India

Rishabh Chalotra is a CSIR-Senior Research Fellow and doctoral scholar at the Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology, Central University of Punjab. His research focuses on addressing the complexities of Metabolic Syndrome through preclinical studies, exploring the therapeutic potential of natural phytoconstituents, and developing herbal-based solutions for improved clinical outcomes. He holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, with extensive experience in animal models, biochemical assays, pharmacokinetic studies, ELISA, RT-PCR, flow cytometry, and other advanced laboratory techniques. Rishabh has contributed to 18 peer-reviewed articles, six book chapters, and four patents, with his work cited 127 times, reflecting an h-index of 6 and an i10-index of 5. His publications explore metabolic disorders, diabetic complications, neurodegenerative diseases, and drug discovery, highlighting the role of flavonoids and natural compounds in therapeutic interventions. He has received the Young Investigator Award from the Indian Pharmacological Society and is a lifetime member of professional societies including the Indian Pharmacological Society, American Society for Microbiology, and British Pharmacological Society. His research combines experimental pharmacology with translational applications to bridge knowledge gaps and improve patient outcomes, positioning him as a promising contributor to global pharmacological research.

Profile: Google Scholar

Featured Publication

Chauhan, S., Chalotra, R., Rathi, A., Saini, M., Deol, S., Lard, M., & Gupta, S. (2023). Current approaches in healing of wounds in diabetes and diabetic foot ulcers. Current Bioactive Compounds, 19(3), 104–121.

Chalotra, R., Gupta, T., Chib, S., Amanat, M., Kumar, P., & Singh, R. (2024). Treatment of diabetic complications: Do flavonoids hold the keys? Critical Reviews in Food Science and Nutrition, 64(30), 11091–11112.

Maqbool, M., Chaudhary, K., Chalotra, R., Chauhan, S., & Dahiya, R. S. (2024). Phyto-pharmacology of most common Indian culinary spices and their potential in developing new pharmaceutical therapies. Current Traditional Medicine, 10(2), 117–140.

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024). Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease. Molecular Biology Reports, 51(1), 586.

Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2025). Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease. Phytotherapy Research, 39(2), 747–775.

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.

Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Assoc. Prof. Dr. Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Shreeyash Institute of Pharmaceutical Education and Research | India

Dr. Sachin Ashok Dhawale is a dedicated researcher in medicinal chemistry and pharmaceutical sciences, recognized for his contributions to drug design, molecular modeling, and synthetic chemistry. With a strong academic foundation including a PhD in Pharmacy, M.Pharm in Pharmaceutical Chemistry, and a B.Pharm degree, he has built extensive experience across academic and research environments, serving in teaching positions and contributing to funded research projects as a JRF and SRF under national scientific bodies. His scientific impact is reflected in 136 citations, an h-index of 6, and an i10-index of 4, supported by more than 25 Scopus-indexed publications, several as first or corresponding author, and cumulative impact exceeding 50. His research spans anticancer agents, antimicrobial molecules, molecular docking, natural product-based therapeutics, ADMET studies, and computational chemistry approaches. He has guided multiple undergraduate and postgraduate research projects, presented papers at national and international conferences, and published a specialized book on computer-aided drug design. His work has earned several recognitions including first-prize awards at competitive scientific events and fellowship support from national and state agencies. With expertise in advanced cheminformatics tools and synthetic techniques, he continues to contribute to innovative therapeutic discovery aimed at improving human health.

Profile: Google Scholar | Orcid

Featured Publications

Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M. A., … Dhawale, S. A. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 9(9).

Singu, P. S., Kanugala, S., Dhawale, S. A., Kumar, C. G., & Kumbhare, R. M. (2020). Synthesis and pharmacological evaluation of some amide functionalized 1H-benzo[d]imidazole-2-thiol derivatives as antimicrobial agents. ChemistrySelect, 5(1), 117–123.

Dube, P. N., Sakle, N. S., Dhawale, S. A., More, S. A., & Mokale, S. N. (2019). Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 13.

Gawai, A. A., Kharat, A. R., Chorge, S. S., & Dhawale, S. A. (2023). Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. Journal of Molecular Recognition, 36(10), e3051.

Suryawanshi, R. M., Shimpi, R. B., Muralidharan, V., Nemade, L. S., Gurugubelli, S., … Dhawale, S. A. (2025). ADME, toxicity, molecular docking, molecular dynamics, glucokinase activation, DPP-IV, α-amylase, and α-glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 22(5), e202402738.